By creating a free Inderes account, you get access to Inderes analysis, you can order the popular morning review and follow companies and discussions that interest you.
Already have an account?
Follow this company like 10885 other investors.
Analyytikko
Redeye keeps its valuation range and base case unchanged despite a lowered revenue and EBIT expectation in 2023. Since decreased budget assumptions only have an impact on Remedy’s short-term revenue, we are still optimistic regarding its more long-term prospects, due to the fact that a lower budget in our view increases the royalty opportunity.
Read more and download the Research Update.
Redeye keeps its valuation range and base case unchanged despite a lowered revenue and EBIT expectation in 2023.
Remedy Entertainment Plc | Stock Exchange Release November 28, 2022, at 4.00 p.m. (EET)
Remedy Entertainment Plc: Tencent Holdings Limited's shareholding in Remedy has gone above the 5 percent threshold
Remedy Entertainment Plc has on November 25, 2022, received a notification under Chapter 9, Section 5 of the Finnish Securities Markets Act according to which Tencent Holdings Limited's indirect shareholding of Remedy shares and voting rights has gone above the 5 percent threshold on November 25, 2022.
Remedy Entertainment Plc | Inside information November 11, 2022 at 2 p.m. (EET)
Remedy Entertainment signs a co-development and co-publishing agreement with 505 Games for Control 2
Remedy Entertainment ("Remedy") has signed an agreement with 505 Games, an international video game publisher and a subsidiary of Digital Bros Group, under which Remedy and 505 Games will co-develop and co-publish Control 2 (formerly known as Codename Heron), a sequel to Remedy's award-winning game Control.
Remedy's Q3 figures were softer than expected due to timing factors, but generally there was nothing surprising in the report. Remedy is now building the next growth leap of its strategy with the 5 major gaming projects under development.
Revenues came in lower than expected during the quarter. However, Remedy communicated in its outlook that the company still expects its revenue to remain at the previous year’s level, which means a big chunk of revenue is expected in Q4.
Remedy Entertainment Plc | Stock Exchange Release October 28, 2022, at 9:00 a.m. (EEST)Remedy Entertainment Plc | Business Review January-September 2022Remedy's investments in game projects continued, burdening profitabilityThe next major game launch, Alan Wake 2, taking place as planned in 2023 The Business Review is unaudited. Figures in parentheses refer to the comparison period in the previous year unless otherwise stated.
Remedy Entertainment Plc | Stock Exchange Release October 28, 2022, at 9:00 a.m. (EEST)
Remedy Entertainment Plc | Business Review January-September 2022
Remedy's investments in game projects continued, burdening profitability
The next major game launch, Alan Wake 2, taking place as planned in 2023
The Business Review is unaudited. Figures in parentheses refer to the comparison period in the previous year unless otherwise stated.
Remedy Entertainment Plc | Stock Exchange Release October 28, 2022, at 8:45 a.m. (EEST)
Remedy Entertainment Plc's financial reporting and Annual General Meeting 2023
Financial statements release 2022 on Friday, February 10, 2023
Business review for January-March 2023 on Wednesday, April 26, 2023
Half-year financial report for January-June 2023 on Friday, August 11, 2023
Redeye lowers its expectations and valuation on Remedy. However, we expect a steady build-up period will be initiated at the beginning of 2023 when game projects move into the next phase of development. The Remedy stock is traded at half its value since our research update in April where we lowered our estimates and valuation. As in our initial coverage report in late 2018, we yet again state that Remedy offers investors “Premium at a discount”.
Redeye lowers its expectations and valuation on Remedy. However, we expect a steady build-up period will be initiated at the beginning of 2023 when game projects move into the next phase of development.
